From Biscuit Business to Biotech
This next-gen biotech firm transforms a 1920s warehouse into a clinical lab advancing cancer immunotherapy.
Clinical Lab & Office
Birmingham, AL
IN8bio, a clinical-stage biotechnology company pioneering cellular cancer therapies, continues to grow its portfolio of gene-modified and chemotherapy-resistant T-cell therapies. With the expansion of its research initiatives, the company needed to centralize its scientific operations and create space for future growth.
To meet this need, IN8bio selected the Martin Biscuit Building, a historic 1928 warehouse in Birmingham, Alabama, as the location for its research and development hub. The project called for a complete interior transformation into a modern biotechnology lab while preserving the site’s character.
The new clinical lab and office facility includes a BSL-2 laboratory equipped for allogeneic, autologous, and genetically modified gamma-delta T cell therapies. The design right-sizes R&D spaces to meet scientific demands, streamlines adjacencies between lab, office, and support zones, and enhances material and personnel flow.
Upgrades include rooftop equipment and structural support, as well as renovated administrative and collaboration spaces that reinforce IN8bio’s research culture.
